Target
Angiotensin-converting enzyme 2
Ligand
BDBM85556
Substrate
n/a
Ki
1000±n/a nM
Comments
PDSP_310
Citation
 Handa, RKHarding, JWSimasko, SM Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. J Pharmacol Exp Ther 291:1242-9 (1999) [PubMed] 
Target
Name:
Angiotensin-converting enzyme 2
Synonyms:
ACE2 | ACE2_BOVIN | Angiotensin IV
Type:
Enzyme Catalytic Domain
Mol. Mass.:
93046.63
Organism:
BOVINE
Description:
Angiotensin IV 0 BOVINE::Q58DD0
Residue:
804
Sequence:
MTGSFWLLLSLVAVTAAQSTTEEQAKTFLEKFNHEAEDLSYQSSLASWNYNTNITDENVQKMNEARAKWSAFYEEQSRMAKTYSLEEIQNLTLKRQLKALQHSGTSALSAEKSKRLNTILNKMSTIYSTGKVLDPNTQECLALEPGLDDIMENSRDYNRRLWAWEGWRAEVGKQLRPLYEEYVVLENEMARANNYEDYGDYWRGDYEVTGAGDYDYSRDQLMKDVERTFAEIKPLYEQLHAYVRAKLMHTYPSYISPTGCLPAHLLGDMWGRFWTNLYSLTVPFEHKPSIDVTEKMENQSWDAERIFKEAEKFFVSISLPYMTQGFWDNSMLTEPGDGRKVVCHPTAWDLGKGDFRIKMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPYLLRNGANEGFHEAVGEIMSLSAATPHYLKALGLLAPDFHEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKQQWMEKWWEMKREIVGVVEPLPHDETYCDPACLFHVAEDYSFIRYYTRTIYQFQFHEALCKTAKHEGALFKCDISNSTEAGQRLLQMLRLGKSEPWTLALENIVGIKTMDVKPLLNYFEPLFTWLKEQNRNSFVGWSTEWTPYSDQSIKVRISLKSALGENAYEWNDNEMYLFQSSVAYAMRKYFSEARNETVLFGEDNVWVSDKKPRISFKFFVTSPNNVSDIIPRTEVENAIRLSRDRINDVFQLDDNSLEFLGIQPTLGPPYEPPVTIWLIIFGVVMGVVVIGIVVLIFTGIRNRRKKNQASSEENPYGSVDLNKGENNSGFQNIDDVQTSL
  
Inhibitor
Name:
BDBM85556
Synonyms:
Ang(1-7)
Type:
Small organic molecule
Emp. Form.:
C41H62N12O11
Mol. Mass.:
899.0048
SMILES:
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(O)=O |wU:47.47,8.17,20.21,wD:4.4,24.32,35.36,60.63,2.2,(13.52,3.66,;12.19,2.89,;12.19,1.35,;13.52,.58,;10.85,.58,;10.85,-.96,;12.19,-1.73,;13.52,-.96,;12.19,-3.27,;10.85,-4.04,;10.85,-5.58,;9.52,-6.35,;9.52,-7.89,;10.85,-8.66,;10.85,-10.2,;12.19,-7.89,;12.19,-6.35,;13.52,-4.04,;14.85,-3.27,;14.85,-1.73,;16.19,-4.04,;17.52,-3.27,;18.85,-4.04,;18.85,-5.58,;20.19,-3.27,;20.19,-1.73,;21.52,-.96,;21.52,.58,;22.86,1.35,;22.86,2.89,;24.19,3.66,;21.52,3.66,;21.52,-4.04,;22.86,-3.27,;22.86,-1.73,;24.19,-4.04,;24.19,-5.58,;25.52,-3.27,;26.86,-4.04,;28.19,-3.27,;26.86,-5.58,;16.19,-5.58,;17.52,-6.35,;14.85,-6.35,;9.52,1.35,;8.18,.58,;9.52,2.89,;8.18,3.66,;6.85,2.89,;5.52,3.66,;5.36,5.19,;3.85,5.51,;3.08,4.18,;4.11,3.03,;8.18,5.2,;6.85,5.97,;9.52,5.97,;10.93,5.34,;11.96,6.49,;11.19,7.82,;9.68,7.5,;8.53,8.53,;8.86,10.04,;7.07,8.06,)|
Structure:
Search PDB for entries with ligand similarity: